SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-153432
Filing Date
2021-05-06
Accepted
2021-05-06 17:01:59
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d181061d424b5.htm 424B5 193911
2 GRAPHIC g179648g03z00.jpg GRAPHIC 33549
3 GRAPHIC g181061g02v00.jpg GRAPHIC 33632
4 GRAPHIC g181061g17x00.jpg GRAPHIC 43888
  Complete submission text file 0001193125-21-153432.txt   336496
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255833 | Film No.: 21898785
SIC: 2834 Pharmaceutical Preparations